Found: 11
Select item for more details and to access through your institution.
Memory NK Cell Features Exploitable in Anticancer Immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tumor-Targeting anti-cD20 antibodies Mediate In Vitro expansion of Memory natural Killer cells: impact of cD16 affinity ligation conditions and In Vivo Priming.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01031
- By:
- Publication type:
- Article
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 4, p. 501, doi. 10.1007/s00262-020-02482-2
- By:
- Publication type:
- Article
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1295, doi. 10.1007/s00262-017-2026-7
- By:
- Publication type:
- Article
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2500, doi. 10.3390/cancers13102500
- By:
- Publication type:
- Article
Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature .
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1199754
- By:
- Publication type:
- Article
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature .
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1043631
- By:
- Publication type:
- Article
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1043631
- By:
- Publication type:
- Article
A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 3, p. 1, doi. 10.1371/journal.ppat.1003202
- By:
- Publication type:
- Article
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00531-8
- By:
- Publication type:
- Article
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 625, doi. 10.3390/biomedicines10030625
- By:
- Publication type:
- Article